http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1806340-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_065fe7c4146d471ac47823ff7c1d911f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42 |
filingDate | 2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2156852e07679805b8b85689b7a1f75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bba25f299c01a8ce5bd1883a939ec7d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7c73bd2af6f1a7a7cd044b25cae21e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46df35a2b19d2333c353e04cdf10c25 |
publicationDate | 2011-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1806340-B1 |
titleOfInvention | Indoline compound and process for producing the same |
abstract | A process for industrially producing silodosin, which is a therapeutic agent for urination disorders accompanying prostatic hypertrophy. The process for silodosin production is characterized by mixing 3-{7-cyano-5-[(2R)-2-({2[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3dihydro-1H-indol-1-yl}propyl benzoate with oxalic acid to yield an oxalate, subsequently hydrolyzing the oxalate to yield 1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carbonitrile, and hydrolyzing it. Also provided is an intermediate for use in the production. |
priorityDate | 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.